Tate & Lyle

Ticker TATE

Today's data summary

Market closed
% change
+0.83%
Price Pence
725.40
Change
+6.00
As of 17:56 21 Feb 2019
Market cap. Pound sterling
3,391.39 million
As of 17:56 21 Feb 2019

Latest updates

US opioid shortage lifts Hikma

Injection
Get

Hikma Pharmaceuticals is leading the FTSE 250 this morning, up 7.5% at £20.62, after it lifted its sales forecast as it supplies more opioid painkillers to the US which is experiencing a shortage.

Its full-year outlook has been boosted by both its injectables division and its generic drugs business.

Auto Trader's shares made good gains, 3.4% ahead at 454.2p, following a 9% rise in interim pre-tax profits to £114.5m on sales 7% higher at £176.8m.

Shares in sugar and sweeteners firm Tate & Lyle rose 2.9% to 705.4p on higher interim sales and profits.

The FTSE 250 is up 0.85% at 19,309.42.

Satellite operator Inmarsat is the biggest faller on the FTSE 250, down 4.8% at 438.3p after it said it would at least meet the lower end of full year revenue forecasts of between $1.3bn and $1.5bn after sales fell by 6% in its maritime business.

Good morning!

Welcome to Business Live and a very busy day for company results.

The big names reporting today include Sainsbury's - following M&S and Morrisons earlier this week - and pharmaceutical giant AstraZeneca.

Sugar firm Tate & Lyle will also its latest financials as will luxury fashion house Burberry.

As always we'd love to hear from you. Email us at bizlivepage@bbc.co.uk